Steven Hyman

Last updated
Steven Hyman
Alma mater
Awards
Academic career
Institutions
External videos
Nuvola apps kaboodle.svg 2016 Sarnat Prize Winner- Dr. Steven Hyman, March 14, 2017
Nuvola apps kaboodle.svg “What DSM-5, Updated Mental Health ‘Bible,’ Means for Diagnosing Patients”, Judy Woodruff, Michael First & Steven Hyman, PBS NewsHour, May 20, 2013.

Steven Edward Hyman is Director of the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard in Cambridge, Massachusetts. [1] He is also Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. Hyman was Provost of Harvard University from 2001 to 2011 and before that Director of the U.S. National Institute of Mental Health (NIMH) from 1996 to 2001. [2] Hyman received the 2016 Rhoda and Bernard Sarnat International Prize in Mental Health from the National Academy of Medicine for "leadership in furthering understanding and treatment of psychiatric disorders as biological diseases". [3]

Contents

Early life and education

Hyman grew up in Teaneck, New Jersey, and graduated in 1970 from Teaneck High School. There he captained the wrestling team and was described by his fellow graduates as the "class intellect". [4]

Hyman received his B.A. from Yale College; an M.A. from the University of Cambridge, which he attended as a Mellon fellow studying the history and philosophy of science; and his M.D. from Harvard Medical School. [2] [5] After an internship in medicine at Massachusetts General Hospital (MGH, 1980–1981), a residency in psychiatry at McLean Hospital (1981–1984), and a clinical and research fellowship in neurology at MGH (1983–1984), Hyman became a postdoctoral fellow at Harvard in molecular biology (1984–1989). [6]

Career

In 1989 Hyman was appointed an assistant professor of psychiatry at Harvard. In 1993 he became an associate professor. [7] He was also director of research in the department of psychiatry at Massachusetts General Hospital from 1992 to 1996 and served as the inaugural faculty director of Harvard’s Interfaculty Initiative in Mind/Brain/Behavior from 1994 to 1996. [8]

Hyman left Harvard to become the director of the National Institute of Mental Health (NIMH) from 1996 to 2001. Part of the National Institutes of Health (NIH), a group of agencies that fund and perform biomedical research, NIMH supports neuroscience and the knowledge needed to understand, diagnose, and treat brain disorders. [9]

Hyman returned to Harvard University as Provost from December 2001 [10] [9] [11] to June 2011. [10] [12] As Provost, he was instrumental in the development of a number of interdisciplinary initiatives both within and between institutions. [13] In 2009 he initiated an extensive process of reform of the Harvard libraries, [14] and he paved the way for the creation of an open access mandate at Harvard. [15] He was also involved in the development of Conflict of Interest guidelines to be applied across the entire institution. [16]

Having stepped down as Provost, Hyman returned to research as the Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology in July 2011. [12] [10] As of February 15, 2012, he succeeded Edward Scolnick as director of the Broad Institute of MIT and Harvard’s Stanley Center for Psychiatric Research. [17]

In 2000 Hyman became a member of the Institute of Medicine (IOM), which became the National Academy of Medicine as of 2015. He has served on its Board of Health Science Policy, spent two terms on its Governing Council (2012-2018), and represented the Governing Council as member to the Governing Board of the National Research Council (2016-2019). From 2012-2018 Hyman chaired the US National Academies' Forum on Neuroscience and Nervous System Disorders. [2]

Hyman is a Fellow of the American College of Neuropsychopharmacology [18] a Fellow of the American Academy of Arts and Sciences (2004), [19] a Fellow of the American Association for the Advancement of Science (2011), [20] and a Distinguished Life Fellow of the American Psychiatric Association. [21] [10]

From 2003–2017 Hyman was the editor of the Annual Review of Neuroscience . [22] [23] He serves on the Board of Directors of Annual Reviews. [24] He is a founding member of the International Neuroethics Society, serving as its first President (2008–2014), [25] Hyman also served as president of the Society for Neuroscience (2014–2015) [26] and president of the American College of Neuropsychopharmacology (2018). [27]

Research

Hyman's research addresses the intersections between molecular biology, neuroscience, genetics, and psychiatry. Through his own research, as well as in his leadership positions at various institutions, he has emphasized the importance of fundamental research connecting genetics, the brain and behavior; of translating basic research into research and treatments for mental disorders; of carrying out extensive and carefully constructed clinical trials that engage with broad and diverse populations; and of studying disorders in childhood. [8]

New information about the genetics, biology, and neuroscience underlying mental disorders is leading to a rethinking of the classification systems for mental disorders. There is increasing recognition that many mental disorders are quantitative deviations from health rather than categorically different from each other. Hyman works to reassess psychiatric classifications of mental disorders, and has helped to draft editions of the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases, Mental and Behavioral Disorders. [28] [29] [30]

Books

Author

Editor

Related Research Articles

<span class="mw-page-title-main">National Institute of Neurological Disorders and Stroke</span> Department of the U.S. National Institutes of Health

The National Institute of Neurological Disorders and Stroke (NINDS) is a part of the U.S. National Institutes of Health (NIH). It conducts and funds research on brain and nervous system disorders and has a budget of just over US$2.03 billion. The mission of NINDS is "to reduce the burden of neurological disease—a burden borne by every age group, every segment of society, and people all over the world". NINDS has established two major branches for research: an extramural branch that funds studies outside the NIH, and an intramural branch that funds research inside the NIH. Most of NINDS' budget goes to fund extramural research. NINDS' basic science research focuses on studies of the fundamental biology of the brain and nervous system, genetics, neurodegeneration, learning and memory, motor control, brain repair, and synapses. NINDS also funds clinical research related to diseases and disorders of the brain and nervous system, e.g. AIDS, Alzheimer's disease, epilepsy, muscular dystrophy, multiple sclerosis, Parkinson's disease, spinal cord injury, stroke, and traumatic brain injury.

The National Institute of Mental Health (NIMH) is one of 27 institutes and centers that make up the National Institutes of Health (NIH). The NIH, in turn, is an agency of the United States Department of Health and Human Services and is the primary agency of the United States government responsible for biomedical and health-related research.

David Gil Amaral is a professor of psychiatry at the University of California, Davis, United States, and since 1998 has been the research director at the M.I.N.D. Institute, an affiliate of UC Davis, engaged in interdisciplinary research into the causes and treatment of autism and related neurodevelopmental disorders. Amaral joined the UC Davis faculty as a professor in the Department of Psychiatry and the Center for Neuroscience and as an investigator at the California Regional Primate Research Center in 1991. Since 1995, he has been a professor of psychiatry in the UC Davis School of Medicine, with an appointment to the UC Davis Center for Neuroscience.

<span class="mw-page-title-main">Leon Eisenberg</span> American psychiatrist (1922–2009)

Leon Eisenberg was an American child psychiatrist, social psychiatrist and medical educator who "transformed child psychiatry by advocating research into developmental problems".

F. Xavier Castellanos is a Bolivian neuroscientist who is the director of research at the NYU Child Study Center. His work aims at elucidating the neuroscience of ADHD through structural and functional brain imaging studies, collaborating on molecular genetic studies, and coordinating an interdisciplinary network of translational investigators. Dr. Castellanos chaired the NIH ‘Initial Review Group’ on Developmental Psychopathology and Developmental Disabilities from 2005–2007 and is chairing the revision of the diagnostic criteria for externalizing disorders for the forthcoming edition of DSM-V, projected for 2012. He continues to make significant contributions to research into the neurobiological substrates of attention deficit hyperactivity disorder.

Paul Stuart Appelbaum is an American psychiatrist and a leading expert on legal and ethical issues in medicine and psychiatry.

Frederick King Goodwin was an American psychiatrist and Clinical Professor of Psychiatry at the George Washington University Medical Center, where he was also director of the Center on Neuroscience, Medical Progress, and Society. He was a specialist in bipolar disorder and recurrent depression.

<span class="mw-page-title-main">Dennis S. Charney</span> American medical researcher

Dennis S. Charney is an American biological psychiatrist and researcher, with expertise in the neurobiology and treatment of mood and anxiety disorders. He is the author of Neurobiology of Mental Illness, The Physician's Guide to Depression and Bipolar Disorders and Molecular Biology for the Clinician, as well as the author of over 600 original papers and chapters. In 2022, he was listed #49 on Research.com's "Top Medicine Scientists in the United States," with an h-index of 218 with 173,960 citations across 887 publications. Charney is known for demonstrating that ketamine is effective for treating depression. Ketamine's use as a rapidly-acting anti-depressant is recognized as a breakthrough treatment in mental illness.

<span class="mw-page-title-main">Thomas R. Insel</span> American neuroscientist (born 1951)

Thomas Roland Insel is an American neuroscientist, psychiatrist, entrepreneur, and author who led the National Institute of Mental Health (NIMH) from 2002 until November 2015. Prior to becoming Director of NIMH, he was the founding Director of the Center for Behavioral Neuroscience at Emory University in Atlanta, Georgia. He is best known for research on oxytocin and vasopressin, two peptide hormones implicated in complex social behaviors, such as parental care and attachment. He announced on Sept. 15, 2015, that he was resigning as the director of the NIMH to join the Life Science division of Google X. On May 8, 2017, CNBC reported that he had left Verily Life Sciences. Insel is a Co-founder with Richard Klausner and Paul Dagum of a digital mental health company named "Mindstrong," a Bay-area startup. He has also co-founded Humanest Care, NeuraWell Therapeutics, and MindSite News and is a member of the scientific advisory board for Compass Pathways, a company that is developing the psychedelic drug psilocybin to treat depression and other mental health disorders. His book, Healing: Our Path from Mental Illness to Mental Health was published by Penguin Random House in February, 2022.

Susan Swedo is a researcher in the field of pediatrics and neuropsychiatry. Beginning in 1998, she was Chief of the Pediatrics & Developmental Neuroscience Branch at the US National Institute of Mental Health. In 1994, Swedo was lead author on a paper describing pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS), a controversial hypothesis proposing a link between Group A streptococcal infection in children and some rapid-onset cases of obsessive-compulsive disorder (OCD) or tic disorders such as Tourette syndrome. Swedo retired from the NIH in 2019, and serves on the PANDAS Physician Network.

<span class="mw-page-title-main">Jeffrey Lieberman</span> American psychiatrist (born 1948)

Jeffrey Alan Lieberman is an American psychiatrist who specializes in schizophrenia and related psychoses and their associated neuroscience (biology) and pharmacological treatment. He was principal investigator for CATIE, the largest and longest independent study ever funded by the United States National Institute of Mental Health to examine existing pharmacotherapies for schizophrenia. He was president of the American Psychiatric Association from May 2013 to May 2014.

<span class="mw-page-title-main">Research Domain Criteria</span> Diagnostic framework in personalized psychiatry

The Research Domain Criteria (RDoC) project is an initiative of personalized medicine in psychiatry developed by US National Institute of Mental Health (NIMH). In contrast to the Diagnostic and Statistical Manual of Mental Disorders (DSM) maintained by the American Psychiatric Association (APA), RDoC aims to address the heterogeneity in the current nosology by providing a biologically-based, rather than symptom-based, framework for understanding mental disorders. "RDoC is an attempt to create a new kind of taxonomy for mental disorders by bringing the power of modern research approaches in genetics, neuroscience, and behavioral science to the problem of mental illness."

The Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard is a multi-disciplinary biomedical research program located in Cambridge, Massachusetts that studies the biological basis of psychiatric disease.

<span class="mw-page-title-main">Lori L. Altshuler</span> American psychiatrist (1957–2015)

Lori Altshuler was a professor at the University of California, Los Angeles (UCLA) Department of Psychiatry and Biobehavioral Sciences and held the Julia S. Gouw Endowed Chair for Mood Disorders. Altshuler was the Director of the UCLA Mood Disorders Research Program and the UCLA Women's Life Center, each being part of the Neuropsychiatric Hospital at UCLA.

<span class="mw-page-title-main">Judith L. Rapoport</span> American psychiatrist

Judith L. Rapoport is an American psychiatrist. She is the chief of the Child Psychiatry Branch at the National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH) in Bethesda, Maryland.

Daniel R. Weinberger is a professor of psychiatry, neurology and neuroscience at Johns Hopkins University and Director and CEO of the Lieber Institute for Brain Development, which opened in 2011.

<span class="mw-page-title-main">Oye Gureje</span> Nigerian psychiatrist

Oyewusi Gureje, NNOM is a Nigerian psychiatrist at the University of Ibadan, Nigeria and Director at the World Health Organization Collaborating Centre for Research and Training in Mental Health, Neurosciences, Drug and Alcohol Abuse in the institution. He is also a Professor Extraordinary at the Department of Psychiatry, Stellenbosch University, South Africa. He is best known for his work on epidemiology, nosology and global mental health and as one of the leading voices on mental health service and policy development in Africa. Oye Gureje has published more than 500 peer-reviewed scientific papers, monographs, book chapters, and other reports. He has been listed, since 2004, in the "top 1% cited researchers in the area of psychiatry and psychology" and, according to Clarivate Analytics, he is one of the "most influential scientific minds"

Andreas Meyer-Lindenberg is a German psychiatrist and professor in the Medical Faculty Mannheim at Heidelberg University. He is also the director and CEO of the Central Institute of Mental Health in Mannheim, as well as medical director of their Department of Psychiatry and Psychotherapy. His research includes work on the genetics of complex psychiatric disorders. He has also used neuroimaging to study the neurobiological basis of mental disorders such as Williams Syndrome, and the effects of living in urban areas on mental health and the human brain.

<span class="mw-page-title-main">Ellen Leibenluft</span> American psychiatrist

Ellen Leibenluft is an American psychiatrist and physician-scientist researching the brain mechanisms mediating bipolar disorder and severe irritability in children and adolescents. She is a senior investigator and chief of the mood dysregulation and neuroscience section at the National Institute of Mental Health.

<span class="mw-page-title-main">Joshua A. Gordon</span> American neuroscientist

Joshua A. Gordon is an American neuroscientist and psychiatrist who served as the Director of the National Institute of Mental Health (NIMH) from 2016 to June 2024. He is currently the Chair of the Department of Psychiatry at Columbia University Medical Center (CUMC) and the Director of the New York State Psychiatric Institute (NYSPI).

References

  1. ↑ Reardon S (2014). "Gene-hunt gain for mental health". Nature . 511 (7510): 393. Bibcode:2014Natur.511..393R. doi: 10.1038/511393a . PMID   25056042. S2CID   205081758.
  2. 1 2 3 "Steven Hyman". HSCRB. Retrieved 17 August 2022.
  3. ↑ Cappelucci, Kyra E. (17 October 2016). "Steven Hyman and Robin Murray Receive National Academy of Medicine's Sarnat Award for Their Outstanding Achievements in Improving Mental Health". National Academy of Medicine. Retrieved 17 August 2022.
  4. ↑ Lisberg, Adam. https://www.newspapers.com/newspage/499519815/ "Teaneck product is named No. 2 leader at Harvard; As provost, he will be principal planning officer"], The Record , October 30, 2001. Accessed January 4, 2021, via Newspapers.com . "A 1970 graduate of Teaneck High School was named provost of Harvard University on Monday after serving five years as director of the National Institute of Mental Health. Steven E. Hyman will assume the provost's position in December, making him the principal planning and policy officer of Harvard and second in command to President Lawrence H. Summers.... Hyman, 49, grew up in Teaneck and attended its public schools. He was captain of the Teaneck High School wrestling team and was named 'class intellect' in the senior yearbook."
  5. ↑ "Scientific Leadership: Steven E. Hyman". The Broad Institute. Retrieved 21 May 2013.
  6. ↑ "Hyman, Steven E(dward)". Writers Directory via Encyclopedia.com. 2005. Retrieved 17 August 2022.
  7. ↑ Gellis, David H.; Shoichet, Catherine E. (October 27, 2001). "Summers Selects Provost | News | The Harvard Crimson". www.thecrimson.com. Retrieved 18 August 2022.
  8. 1 2 Wrinn, Joe (25 October 2001). "Steven Hyman named Harvard provost". Harvard Gazette. Retrieved 18 August 2022.
  9. 1 2 McNulty, Jim (Oct 29, 2001). "NIMH Director Steven Hyman to return to Harvard; NAMI praises his leadership as "A hard act to follow". NAMI: National Alliance on Mental Illness (NAMI). Retrieved 18 August 2022.
  10. 1 2 3 4 "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )". Voyager Therapeutics, Inc. 2020. Retrieved 18 August 2022.
  11. ↑ Potier, Beth (13 December 2001). "Hyman back at Harvard". Harvard Gazette. Retrieved 18 August 2022.
  12. 1 2 "Back to the Lab Bench". Harvard Magazine. 22 February 2011. Retrieved 18 August 2022.
  13. ↑ Groll, Elias J.; Weinberg, Zoe A. Y.; White, William N. (December 15, 2010). "Harvard Provost Steven Hyman To Step Down | News | The Harvard Crimson". The Harvard Crimson. Retrieved 18 August 2022.
  14. ↑ "University Libraries' report issued". Harvard Gazette. 12 November 2009. Retrieved 18 August 2022.
  15. ↑ "Open Access Policies". Harvard OSC. Retrieved 18 August 2022.
  16. ↑ Colen, B. D. (21 July 2010). "Conflict of interest policy adopted". Harvard Gazette. Retrieved 17 August 2022.
  17. ↑ "Steven Hyman to lead the Broad Institute's Stanley Center for Psychiatric Research". Broad Institute. 15 February 2012. Retrieved 18 August 2022.
  18. ↑ Neuroscience biomarkers and biosignatures : converging technologies, emerging partnerships : workshop summary. Washington, D.C.: National Academies Press. 2008. p. 101. ISBN   978-0-309-10889-8 . Retrieved 18 August 2022.
  19. ↑ "Steven E. Hyman". American Academy of Arts & Sciences. Retrieved 18 August 2022.
  20. ↑ "AAAS Members Elected as Fellows". American Association for the Advancement of Science. Retrieved 18 August 2022.
  21. ↑ Slightham, Whitney (20 May 2019). "Harvard leader, former NIMH director, to discuss 'genetics of mind' at public lecture in Roanoke". Virginia Tech. Retrieved 18 August 2022.
  22. ↑ "Annual Review of Neuroscience. Volume 26: 2003. Edited by Steven E Hyman, Thomas M Jessell, Carla J Shatz, and , Charles F Stevens. Palo Alto (California): Annual Reviews. $70.00. xii + 762 p + 27 pl; ill.; subject index and cumulative indexes (contributing authors and chapter titles, Volumes 17–26). ISBN: 0–8243–2426–9. 2003". The Quarterly Review of Biology. 79 (2): 224. 2004. doi:10.1086/423107 . Retrieved 29 July 2021.
  23. ↑ "EDITOR OF THE ANNUAL REVIEW OF NEUROSCIENCE - VOLUME 40, 2017". Annual Reviews. Retrieved 29 July 2021.
  24. ↑ "Annual Reviews Board of Directors". Annual Reviews.
  25. ↑ "Leadership". International Neuroethics Society. Retrieved 18 August 2022.
  26. ↑ "Steve Hyman assumes Presidency of Society for Neuroscience". Center for Law, Brain & Behavior. 24 November 2014. Retrieved 18 August 2022.
  27. ↑ "ACNP President's Letter" (PDF). ACNP Bulletin. 24 (2). 2018. Retrieved 18 August 2022.
  28. ↑ Marshall, Michael (5 May 2020). "The hidden links between mental disorders". Nature. 581 (7806): 19–21. Bibcode:2020Natur.581...19M. doi: 10.1038/d41586-020-00922-8 . PMID   32372044. S2CID   218494768.
  29. ↑ International Advisory Group for the Revision of ICD-10 Mental and Behavioural Disorders (June 2011). "A conceptual framework for the revision of the ICD-10 classification of mental and behavioural disorders". World Psychiatry. 10 (2): 86–92. doi:10.1002/j.2051-5545.2011.tb00022.x. PMC   3104876 . PMID   21633677.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  30. ↑ Hyman, Steven E. (2011-04-26). "Diagnosing the DSM: Diagnostic Classification Needs Fundamental Reform". Cerebrum: The Dana Forum on Brain Science. 2011: 6. ISSN   1524-6205. PMC   3574782 . PMID   23447775.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.